These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6312058)

  • 21. Negative inotropic effect of verapamil, nifedipine and prenylamine and its reversal by calcium or isoproterenol.
    Mattiazzi AR; Garay A
    Arch Int Physiol Biochim; 1983 Sep; 91(3):133-44. PubMed ID: 6198983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of AOA 39, D600, verapamil and diltiazem with cardiac cholinergic effects.
    Mubagwa K; Carmeliet E
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):71-84. PubMed ID: 3592862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interaction of calcium antagonists (slow channel blockers) with myocardial alpha adrenoceptors.
    Nayler WG; Thompson JE; Jarrott B
    J Mol Cell Cardiol; 1982 Mar; 14(3):185-8. PubMed ID: 6286984
    [No Abstract]   [Full Text] [Related]  

  • 24. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of verapamil and other calcium antagonists on chemotaxis of polymorphonuclear leukocytes.
    Elferink JG; Deierkauf M
    Biochem Pharmacol; 1984 Jan; 33(1):35-9. PubMed ID: 6704142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow channel inhibitor effects on brain function: tolerance to severe hypoxia in the rat.
    Cartheuser CF
    Br J Pharmacol; 1988 Nov; 95(3):903-13. PubMed ID: 3264735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein.
    Dacquet C; Mironneau C; Mironneau J
    Br J Pharmacol; 1987 Sep; 92(1):203-11. PubMed ID: 2959345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.
    Grover GJ; Sleph PG
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):331-40. PubMed ID: 2476610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium flow-independent actions of calcium channel blockers in toad urinary bladder.
    Levine SD; Levin DN; Schlondorff D
    Am J Physiol; 1983 Mar; 244(3):C243-9. PubMed ID: 6299112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane activity, antioxidant, antiaggregatory and antihemolytic properties of four calcium channel blockers.
    Robak J; Duniec Z
    Pharmacol Res Commun; 1986 Dec; 18(12):1107-17. PubMed ID: 3562505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium antagonistic drugs differ in ability to block the slow Na+ channels of young embryonic chick hearts.
    Kojima M; Sperelakis N
    Eur J Pharmacol; 1983 Oct; 94(1-2):9-18. PubMed ID: 6317401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Ca2+ antagonists on isolated rabbit detrusor muscle.
    Scultéty S; Tamáskovits E
    Acta Physiol Hung; 1991; 77(3-4):269-78. PubMed ID: 1755331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potencies and selectivities of four calcium antagonists as inhibitors of uterine contractions in the rat in vivo.
    Abel MH; Hollingsworth M
    Br J Pharmacol; 1985 May; 85(1):263-9. PubMed ID: 4027469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium antagonists and myocardial protection during cardioplegic arrest.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    Adv Myocardiol; 1985; 6():545-62. PubMed ID: 3992050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue.
    Schwinger RH; Böhm M; Erdmann E
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):892-9. PubMed ID: 1694911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.
    Motulsky HJ; Snavely MD; Hughes RJ; Insel PA
    Circ Res; 1983 Feb; 52(2):226-31. PubMed ID: 6297831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of calcium channel blockers on superoxide anions.
    Shridi F; Robak J
    Pharmacol Res Commun; 1988 Jan; 20(1):13-21. PubMed ID: 2836871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of calcium channel blockers on electrical and mechanical responses of rat phrenic nerve-diaphragm preparations].
    Zupko I; Blazsó G; Minker E
    Acta Pharm Hung; 1995 Jul; 65(4):127-31. PubMed ID: 7572195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.